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Abstract
Autism spectrum disorder (ASD) is a category of neurodevelopmental 
disorders characterized by social and communication impairment and 
restricted or repetitive behaviors. The pathogenesis of ASD is not 
well understood and it’s proved that genetic is strongly associated 
with ASD in 5 to 25% of cases.
Inborn errors of metabolism(IEMs), defined by a vast array of 
disorders that are caused by specific enzyme deficiencies or transport 
protein defects, is as frequent as in 1 in 800 births. IEMs can manifest 
several psychiatric or behavioral manifestations such as self-injuries- 
increased activity and aggression, personality changes, paranoia, 
depression, catatonia, and psychosis. 
 IEMs underlie autistic symptoms in less than 5% of cases. The 
literature on the association between ASD and respiratory chain 
abnormalities is growing, including complex III/IV deficiency 
and MELAS( mitochondrial encephalopathy, lactic acidosis, and 
stroke-like episodes) syndrome, as well as glucose-6-phosphate 
dehydrogenase deficiency.
Google Scholar, Pubmed, and SCOPUS databases were searched 
using a combination of the following keywords: “autism spectrum 
disorder”, “autism spectrum”, “autistic feature” and “inborn error 
of metabolism”, “ IEM”, “congenital error of metabolism”. Initially, 
655 articles were found and our expert and methodologist altogether 
selected 187 articles based on the titles, relevance, and text language. 
After reading full texts, 37 studies were selected for review. 
Conclusion
We think it’s best to consider IEMs in children with syndromic 
ASD and/or if there is a strong familial history of autism or parental 
consanguineous marriage.
Keywords: Autism, Autism Spectrum Disorders, Inborn Errors of 
Metabolism.
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Introduction
Autism spectrum disorder (ASD) is a category 
of neurodevelopmental disorders characterized 
by social and communication impairments 
and restricted or repetitive behaviors.(1) Its 
prevalence in the US population is about 5 
million, which is similar to other industrialized 
countries. Meanwhile, its prevalence is nearly 
1.7% among children.(1)  The terminology and 
diagnostic criteria for ASD vary geographically, 
where The Diagnostic and Statistical Manual of 
Mental Disorders (DSM) is used predominantly 
in the United States (DSM-5, updated 2013)
(2) and World Health Organization International 
Classification of Diseases, 10th revision (ICD-
10) is used in other countries.(3) The DSM-5 
category for identifying ASD is as follow (2): 
According to the first criterion, the deficits must 
be clinically significant and persistent and should 
include the following: (1) marked impairment of 
both verbal and nonverbal communication so that 
social interaction be intervened; (2) lack of social 
reciprocity; and (3) failure to develop appropriate 
peer relationships. The second criterion consists 
of restrictive repetitive interests presented by at 
least 2 of the following: (1) stereotyped motor or 
verbal behaviors or unusual sensory behaviors, 
(2) excessive adherence to routines and ritualized 
patterns of behavior, and (3) restricted, fixated 
interests. Based on the third criterion, the symptoms 
of autism must be presented in early childhood. 
 ASD is more common in boys than girls (a male/
female ratio of 4.2)(4) and happens in nearly 10% 
of an ASD patient’s siblings.(5)
The pathogenesis of ASD is not well studied 
and a strong genetic caustic association is found 
at 5 to 25 percent of cases.(6) However; single-
gene mutations only appear in approximately 
5% of cases which suggests autism is a complex 
multifactorial disorder with multiple genetic 
factors involved as well as environmental 
factors that affect its etiology (7). These factors 
include diagenetic (such as neuroanatomical and 
neuroimaging abnormalities), immunological, and 
metabolic factors.(8) Associated disorders include 
Fragile X syndrome, tuberous sclerosis, Angelman 
syndrome, duplication of 15q11-q13, Rett 
syndrome, Down syndrome, and Cohen syndrome.
(9) Twin studies have reported that concordance 
for autism in monozygotic twins is 36 to 90%, 
which further highlights the influence of genetic-
related factors.(10) However, it was assumed that 
environmental factors do not have an important 
role in findings such as the high prevalence of 
autism in monozygotic twins, which is partly due 
to the limited understanding of gene-environment 
interactions.(11)
To increase the diagnostic yield of autism, few 
issues are to be noted: 
First, a significant number of diagnoses can be 
made by reviewing the patient’s history and 
dysmorphology examination alone. Second, 
careful consideration of medical and genetic tests 
significantly increases diagnostic yield.
Third, diagnostic yield increases with the 
aggressiveness of the evaluation.(6)
Inborn errors of metabolism(IEMs), defined by a 
vast array of disorders that are caused by specific 
enzyme deficiencies or transport protein defects, 
can be as frequently reported as in 1 in 800 births.
(12) These conditions include organic acidemias, 
aminoacidopathies, urea cycle defects, disorders 
of carbohydrate metabolism, lysosomal storage 
disorders, beta-oxidation defects, peroxisomal 
disorders, and mitochondrial disorders. (13) Purine 
metabolism errors, such as adenylosuccinase 
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deficiency and adenosine deaminase deficiency 
and congenital disorders of glycosylation, are 
other IEMs.(14)
IEMs can manifest several psychiatric or behavioral 
manifestations such as self-injuries- increased 
activity and aggression, personality changes, 
paranoia, depression, catatonia, and psychosis.(15)
IEMs cause the autistic features in less than 5% 
of cases. The relationship between ASDs and 
respiratory chain abnormalities, including complex 
III/IV deficiency and MELAS(Mitochondrial 
encephalopathy,Lactic acidosisand Stroke like 
episodes) are found as well as glucose -6-phosphate 
dehydrogenase deficiency in few cases.
. Also, a number of reports suggest metabolic 
imbalances in ASD patients that indicate IEM, 
such as abnormalities of glucose oxidation and 
utilization. In other cases, it’s hard to distinguish 
IEMs as a primary or secondary pathology.(16) 
A study on 274 non-syndromic ASD children 
reported metabolic disturbances in only 2 
children,(10) and the authors suggested to exclude 
routine metabolic screening for these patients. 
In another cohort of 32 patients who were 
referred for genetic evaluation with a diagnosis 
of autism, no patients had abnormal metabolic 
screening (including Urine organic acids and 
mucopolysaccharides, Serum lactic acid, amino 
acids, ammonia, and acyl-carnitine profile)(6).
Not so far ago, a unique set of biomarkers was 
found in ASD children with a proteomic approach 
that carried the potential for the early detection 
of ASD, even with the limited population of the 
study group.(17) Which then also might carry 
the potential for understanding the etiology or 
etiologies of ASD furthermore.
 The current study aimed to narratively review the 
associated metabolic conditions in ASD children 
with or without any previous condition.
Methodology 
Google Scholar, PubMed, and SCOPUS databases 
were searched using the combinations of following 
keywords: “autism spectrum disorder”, “autism 
spectrum”, “autistic feature”, “inborn error of 
metabolism”, “ IEM”, and “congenital error of 
metabolism”. Initially, 655 articles were found and 
our expert and methodologist altogether selected 
187 articles based on the correlation of titles and 
text language. After reading the abstract and full 
texts, a total of 49 studies were selected for review. 
The inclusion and exclusion criteria are shown in 
Table 1.
-Associated disorders
We classified metabolic disorders that manifested 
autistic features in 10 groups (table 2).
Amino acid metabolism
Autistic behavior has been in imbalances in 
neurotransmitter amines function such as dopamine, 
noradrenaline, and serotonin. Hyperserotonemia in 
particular shows a familial pattern and was found 
in over 25% of children and adolescents with 
autism. Amino acids can act as neurotransmitters 
in the central nervous system(CNS). In particular, 
glutamate, which can have an excitatory effect at 
high concentrations.(18, 19)
A study by Aldred, S. et al. analyzed amino acid 
levels of 12 autistic patients and 11 patients 
diagnosed with Asperger syndrome and their 
parents (n=32) and siblings(n=13). The authors 
reported that glutamic acid, phenylalanine, lysine, 
and asparagine were significantly higher (p-value 
0.05) in both children and their parents compared 
to age-matched controls. Besides, they had lower 
levels of glutamine. The study also mentioned that 
the disrupted glutamate/glutamine ratio could be 
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a predisposing factor in the etiology of autism. 
Glutamine is essential for enteric nutrition and 
many gastrointestinal problems are frequently 
reported in children with autistic features.(18)
Phenylalanine
Phenylketonuria(PKU) is an autosomal recessive and 
the most common genetic metabolic disease which 
is associated with ASD.(20) Mental retardation, 
microcephaly, tremor, motor retardation, and 
ADHD are also reported to be associated with PKU. 
The PKU causes by dysfunction of phenylalanine 
hydroxylase (PAH), which is an essential enzyme 
in converting phenylalanine (PHE) to tyrosine. It 
increases the levels of PHE that can be harmful 
to brain development in first years of life, which 
causes variable neurologic manifestations and 
mental impairments. Imbalanced Excitation/
inhibition(E/I) pathway is proposed as a potential 
pathophysiologic mechanism involved in ASD. 
A study that used a PKU model of mice (ENU2) 
further examined this mechanism by examining 
functional and molecular alterations in their 
prefrontal cortex and reported an imbalance in the 
E/I neurotransmission favoring inhibition in the 
prefrontal cortex of ENU2 mice and alterations 
of the molecular components involved in the 
organization of cortical synapse, which helped to 
clarify the pathology of ASD at least in animal 
models.(20) White matter lesions are also one 
of the suggested pathologies for behavioral and 
cognitive problems in PKU, which are further 
corrected by mentioning characteristics of the 
interaction of environmental, genetic, metabolic, 
neurological, and developmental factors in which 
vary in various cases. (21) Early correction of the 
PHE levels appears to cause improved behavioral 
and cognitive function in PKU, even if the PKU is 
diagnosed as late as the age of 3.(21)
Methionine, Cysteine, and Homocysteine
The methionine-folate pathway defect have 
been identified in individuals with ASD. As 
a pathway that plays a critical role in DNA 
synthesis, methylation, and cellular redox balance, 
folate deficiency has been known as a plausible 
predictor for neurodegenerative diseases, such 
as Parkinson’s disease and Alzheimer’s.(11, 22) 
Methionine is an essential amino acid that is 
later converted S-adenosyl-methionine(SAM) 
and acts as the body’s main methyl group donor. 
During the methylation reactions, it converts to 
S-adenosyl-homocysteine(SAH). Homocysteine 
can later be converted to cysteine(and later to form 
glutathione) or remethylated to form methionine 
by methionine synthase(MS). Vitamin B12 is also 
necessary for this conversion.(22-24) An in-depth 
systematic review showed that defects in this cycle 
showed significantly lower levels of methionine, 
SAM and homocysteine and significantly higher 
levels of SAH in children with ASD compared to 
the controls and a later study (however in a lower 
population) showed no significant differences. As 
for the folate metabolism, treatment with folinic 
acid and betaine improves the concentration levels 
of metabolites from the methionine pathway 
in cases with impairments (some studies) and 
adding vitamin B12 further improved their levels. 
Significant behavioral improvements, however, 
were not observed. 
Vitamin B6, which is required for the conversion 
of THF ((tetrahydrofolate) to 5,10-MTHF)5,10-
methylene tetrahydrofolate formed from methylated 
THF and later mostly converted to 5-MTHF) and 
homocysteine to cysteine is significantly higher 
in some children with ASD compared to controls, 
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which can indicate impairments. It is also important 
because impaired bioavailability of B6 can affect 
the CNS, because it is required for the synthesis of 
neurotransmitters such as serotonin, dopamine, and 
taurine.(22, 24, 25) In a case-control study, Omani 
has compared the levels of folate, homocysteine, 
and vitamin B12 in 40 ASD children and 40 
matched controls and reported significantly higher 
levels of homocysteine, folate, and vitamin B12 in 
ASD children compared to the controls. Although 
nutritional factors may be important, defects in the 
folate-methionine cycle should also be considered.
(23)
Organic Acidemia
●  Propionic academia is one of the most com-
mon IEMs that may coexist with autism. In one 
study autism spectrum disorder was frequent in 
patients with propionic academia without any 
correlation between symptoms and 3-hydroxy 
propionate level.(26)
●  Partial Biotinidase deficiencies were reported 
in a 4 year old girl with autistic feature. Se-
vere forms of disease are life threatening, if not 
treated, and can result in many other symptoms.
(27)
●  L-2-Hydroxyglutaric aciduria (L-2-HGA) is 
a rare autosomal recessive metabolic disor-
der that affects exclusively the central nervous 
system and is characterized by a defect in the 
metabolism of L-2-hydroxyglutaric acid and, 
consequently, increased levels of the acid in 
the urine, cerebrospinal fluid, and plasma. 
Mild psychomotor delay in the first years of 
life, followed by progressive cerebellar ataxia, 
dysarthria, and moderate to severe mental de-
terioration, and macrocephaly, pyramidal and 
extrapyramidal signs, seizures, and dystonia 
are common in most of the patients. Language 
deficits, hyperactivity, and a talkative child are 
among the reported behavioral and communica-
tive problems. A case of L-2-HGA has been re-
ported who had manifested severe autism. The 
author reported that even though this finding 
could have been by chance, it is worthwhile for 
the physicians to note autism in children with 
L-2-HGA.(28)
Mitochondrial & Fatty acid metabolism 
disorders
The mitochondria is an intracellular organelle that 
plays a crucial role in adenosine 5′-triphosphate 
(ATP) production through oxidative 
phosphorylation (OXPHOS), which is carried out 
by electron transport chain(ETC).
IEMs contain two types of onsets: first is shortly 
after birth and second is when the child has a 
genetic background, but decompensation occurs 
later in the first years of life. Decompensation also 
can occur secondary to a serious illness or other 
major stresses. The second pattern can be consistent 
in the autistic regression seen in children with 
mitochondrial disease.(29) Mitochondrial disorders 
are also increasingly being recognized as a cause 
or related to the development and persistence of 
epilepsy, which is a common concomitant of ASD.
(30)
A study that has reviewed the prevalence of 
mitochondrial disorders and ASD, theorized 
that if there was no association between ASD 
and mitochondrial-related diseases, it would 
be expected that 1 in 110 subjects with the 
mitochondrial disease would have been ASD 
and 1 in 2000 individuals with ASD would have 
mitochondrial disease. However, their results 
indicated a significant difference which suggested 
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a possible shared pathology.(8)
Fatty acid beta-oxidation disorders are a group 
of inherited diseases that may either be caused 
by the failure of a single mitochondrial, peroxisomal 
enzyme of beta-oxidation or be secondary to 
dysfunction of dependent processes (31).
Mitochondrial fatty acid oxidation (FAO) 
deficiencies usually occur in neonates and 
toddlers and can cause psychomotor delay, 
developmental regression, behavioral disorders, 
and attention deficit as well as cardiomyopathy 
and muscle weakness. Long-chain acyl-CoA 
dehydrogenase (LACD) deficiencies are theorized 
in a case report, presenting an autistic patient 
with the abnormality of the acyl-carnitine profile, 
abnormal ammonia detoxification, and altered 
mitochondrial energy production together with 
hypotonia and possible intermittent dicarboxylic 
aciduria. The acyl-carnitine profile in this 8-year-
old boy showed an abnormality that was mainly 
of an unsaturated specie, particularly C14:2 and 
C14:1. Although elevated C 14:1 could be seen in 
VLACD deficiencies, no other FAO deficiencies 
showed C 14:2. This finding led them to theorize 
that LACD deficiency can be the main cause, 
while cardiomyopathy and muscle weakness are 
prominent in other FAO-related disorders, such 
as VLCAD, increased physiologic turnover of 
unsaturated fatty acids in CNS, Gastrointestinal 
tract, and immune system which occur in autism, 
are more likely to justify these findings.(31, 32) 
Lower plasma levels of polyunsaturated fatty 
acids, elevations in polyunsaturated long-chain 
fatty acids, saturated very-long-chain fatty acids, 
and lipofuscin deposits in the prefrontal cortex 
have also been reported in ASD children compared 
to age-matched controls.(32)
●  Brain carnitine deficiency 
The main role of carnitine is to enable the transfer of 
fatty acids into mitochondria. Carnitine facilitates 
the entry of fatty acids into mitochondria by forming 
covalent acyl-carnitines. A study hypothesized 
that carnitine deficiency in the mitochondria of 
the brain, disturbs neurodevelopment, and cause 
Non-Mendelian, non-dysmorphic (NoMeND) 
autism, because previously low levels of carnitine 
are observed in ASD children and ASD was 
prevalent as common as in 3% of the cases of 
TMLHE deficiency (preventing the synthesis 
of carnitine from trimethyllysine). The results 
on animal models were favorable and the study 
suggested that early treatment with carnitine and 
other micronutrient supplementation may benefit 
recently symptomatic children and reduce the 
recurrence risk both in families and in the general 
population.(33)
●  Creatine transporter deficiency (CTD) and 
cerebral creatine deficiency syndromes 
(CDS)
CTD is a known X-linked IEM that causes by 
mutations in creatine transporter gene (SLC8A8). 
It can cause disturbance of creatine import into 
the cells and cause problems in organs that 
require large amounts of energy such as the brain. 
Intellectual disability (ID), epilepsy, and autistic 
behavior and language disability are its main 
clinical presentations (34). Increased creatine/
creatinine ratio and normal urine guanidinoacetate 
levels are required for the diagnosis of CTD. on the 
other hand, one of the diagnosis criteria of CDS is 
decreased serum creatine levels, which is normal 
in patients with CTD. Clinical presentations of 
CDS include abnormal movements, developmental 
delays, seizures, and autism.(34)
Diagnosis is based on urinary and plasma 
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guanidinoacetate and creatin levels as well as 
neuroimaging studies (MRS).
Vitamins &Minerals 
Disorders in fetal brain development and lack of 
essential nutrition can later cause disorders such as 
neural tube defects and schizophrenia. Therefore, 
probably maternal nutritional imbalance affects 
the risk of ASD.(11) Whether maternal folate 
supplementation reduces the risk of ASD is still an 
open question with many factors that are hard to be 
singled out, however; there are studies which have 
suggested that folate supplementation can reduce 
the probability of ASD in children.(11, 25)
A study on 47 ASD children that were randomly 
assigned to treated with methycobalamin (methyl 
B12) at a dosage of 75 microgram/kg and saline 
placebo group every 3 days for 8 weeks reported 
significant improvements of CGI-improvement 
scale which was positively correlated with 
increased plasma methionine, decreased SAH, and 
improved SAM to SAH ratio (35). 
Muccopolysachariosis
●  Learning disorders and mental retardation are 
common presentations of Mucopolysaccharido-
sis (Hurler and Hunter syndromes);
●  Sanfilippo syndrome or Mucopolysaccharidosis 
(MPS) type III is an inherited lysosomal stor-
age defect that can cause severe neurodegen-
erative course. Patients with MPS type III have 
partially-degraded accumulated heparin sulfate 
fragments. MPS-IIIA and -IIIB patients of simi-
lar ages show similar neurocognitive impair-
ment, and autistic features present in one-third 
of the children diagnosed with MPS type IIIA.
(36) 
Smith–Lemli–Opitz syndrome (SLOS)
Smith–Lemli–Opitz syndrome (SLOS) is an 
autosomal recessive condition caused by a defect 
in cholesterol synthesis leading to increased serum 
levels of 7-dehydrocholestrol. In a study, using the 
DSM-IV checklist, 14 children diagnosed with 
SLOS were evaluated for ASD and 7 of them scored 
at or above the cutoff for autistic disorder. They 
suggested that the observed association between 
autism and a defect in cholesterol metabolism 
suggests that cholesterol metabolism is not only 
linked to the pathogenesis of autism in SLOS, but 
also to autism in general.(9)
Androgen theory of autism
The androgen theory of autism proposes that 
autism spectrum conditions (ASC) are in part 
due to elevated fetal testosterone (FT) levels. 
Significantly higher male to female ratio sparked 
the idea that the autistic brain might be an “extreme” 
of the typical male brain. Increased FT measured 
in amniotic fluid can highly be correlated with 
the amount of eye contact at 12 months of age, 
vocabulary size at 18 and 24 months, and quality 
of social relationships at 4 years. It also correlates 
with some autistic features(37). A survey on 54 
women with ASC, 74 mothers of ASC children, 
and 183 mothers of normal children which used 
Testosterone-related Medical Questionnaire (TMQ) 
showed significantly higher rates of hirsutism, 
polycystic ovarian syndrome, and other androgen-
related conditions in most cases and conditions. 
It also argued that elevated testosterone level is a 
common risk factor for hyperandrogenism in adult 
women and those with autism, rather than any of 
the conditions such as hirsutism causing autism.
(37) 
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Table 1. Inclusion& Exclusion criterias in our study
Inclusion criteria Exclusion criteria
Articles that were about IEMs of metabolism, autism, and 
other matters of interest to the authors
Any language other than English
Availability of full text or abstract Articles before 2009/ If the chronological view isn’t 
reviewed
Table 2. Classification of IEMs those presented with Autistic features
Aminoacidopathies Organic Acidemia&Aciduria
Fatty acid Metabolism Vitamins & Minerals Related Disorders
Carnitine related disorders Mucopolysacharidosis
Mitochondrial Disorders Urea Cycle defect
Creatin Related Disorders Miscellaneous
Purine & Pyrimidine Disorders
Table 3. Clues for metabolic based autistic features
Coexist symptoms Lab Tests Diagnosis
ASD+Microcephaly • HPLC of AA PKU,Serin deficiency,
ASD +Abnormal 
Movements+Epilepsy
• Creatin Pannel Cerebral Creatin Deficiency syndromes
Distinct Syndromic appearence • Cholestrol pannel Smith lemli opitz
Self Mutilation • Uric acid Lesh nyhan syndrome
Coarse Facies +ASD • Urin Mucopolysacharides Sanfilippo 
ASD+acidosis • Biotine panel
• Urinary organic acids
• Lactat
Biotinidase deficienct
Organic academia
Mitochondrial disorders
Lactate pathway 
Macrocytic anemia+ASD • B12,Folate MMA
Homocystinuria
Vitamins deficiency
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Table ????. 
Inclusion criteria Exclusion criteria
Articles that were about IEMs of metabolism, autism, and 
other matters of interest to the authors
Any language other than English
Availability of full text or abstract Articles before 2009/ If the chronological view isn’t 
reviewed
Figure 1. Algorithm of narrative review search about participation of articles
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In conclusion
although IEM may be relate to a small number 
of ASDs in general,; we can’t ignore the growing 
evidence about IEMs association with ASD. We 
think it’s best to consider IEMs in children with 
syndromic ASD and/or if a strong familial history 
of autism is observed, consanguineous marriage, 
and clinical suspicion. Besides, performing 
standard metabolic screening would be useful in 
these cases.(Table 3)
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